Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C

by Beth A. Taylor, Gregory Panza, Linda S. Pescatello, Stuart Chipkin, Daniel Gipe, Weiping Shao, C. Michael White, Paul D. Thompson
Published 2014-01-01